Li Chunyang, Li Yujian, Wu Shaoyan, Li Gui, Li Juan, Zhao Yan, Cai Huan, Shu Jia, Song Mingxuan, Fu Qing, Yuan Jianbo, Gao Xin, Ai Zhujun, Li Xiaosong, Chen Rui, Zuo Zhong
Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, 400016, China.
Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Orthopedics Research Laboratory, Chongqing Medical University, Chongqing, 400016, China.
Small Methods. 2025 Jan;9(1):e2400738. doi: 10.1002/smtd.202400738. Epub 2024 Jul 31.
Catalytic nanoparticle@metal-organic framework (MOF) composites have attracted significant interest in point-of-care testing (POCT) owing to their prominent catalytic activity. However, the trade-off between high loading efficiency and high catalytic activity remains challenging because high concentrations of nanoparticles tend to cause the misjoining and collapse of the MOFs. Herein, a facile strategy is reported to encapsulate high concentrations of platinum (Pt) nanoparticles into zeolitic imidazolate framework-8 (ZIF-8) using polydopamine (PDA) as a support for Pt@ZIF-8 and as a flexible scaffold for further immobilization of Pt nanoparticles. The resulting composite (Pt@ZIF-8@PDA@Pt) exhibits ultrahigh Pt nanoparticle loading efficiency, exceptional catalytic activity, stability, and a bright colorimetric signal. Following integration with lateral flow immunoassay (LFIA), the detection limits for pre- and post-catalysis detection of B-type natriuretic peptide (NT-proBNP) are 0.18 and 0.015 ng mL, respectively, representing a 6-fold and 70-fold improvement compared to gold nanoparticle-based LFIA. Moreover, Pt@ZIF-8@PDA@Pt-based LFIA achieves 100% diagnostic sensitivity for NT-proBNP in a cohort of 184 clinical samples.
催化纳米颗粒@金属有机框架(MOF)复合材料因其突出的催化活性而在即时检测(POCT)领域引起了广泛关注。然而,高负载效率和高催化活性之间的权衡仍然具有挑战性,因为高浓度的纳米颗粒往往会导致MOF的错连和坍塌。在此,我们报道了一种简便的策略,即使用聚多巴胺(PDA)作为Pt@ZIF-8的载体以及进一步固定铂纳米颗粒的柔性支架,将高浓度的铂(Pt)纳米颗粒封装到沸石咪唑酯骨架-8(ZIF-8)中。所得复合材料(Pt@ZIF-8@PDA@Pt)表现出超高的Pt纳米颗粒负载效率、出色的催化活性、稳定性以及明亮的比色信号。与侧向流动免疫分析(LFIA)集成后,B型利钠肽(NT-proBNP)催化前后检测的检测限分别为0.18和0.015 ng/mL,与基于金纳米颗粒的LFIA相比,分别提高了6倍和70倍。此外,基于Pt@ZIF-8@PDA@Pt的LFIA在184例临床样本队列中对NT-proBNP的诊断敏感性达到100%。